Home / 2014 / November (page 3)

Monthly Archives: November 2014

Pocket Pal

Pocket Pal  Pocket Pal is a blood glucose meter with a built-in lancing device and a pull-out compartment that holds 25 test strips. A small piece of the Dario detaches from the meter and connects to a smartphone headphone jack, linking the meter to a Dario app. After logging into …

Read More »

Letter from the Editor, #757

When Walmart first introduced their $4 generic drug program we thought that it would be an oddity for a month or two and then go away. Then everyone jumped on the bandwagon and soon these programs were so commonplace that our patients felt anything over $4 was too much. Studies …

Read More »

Editor’s Note, DCMS #216

Every time we talk to a patient newly diagnosed with diabetes we talk about the kidneys, the feet, and the eyes, and what can happen if we let our glucose levels run rampant. We focus on this because the concept of microvascular complications has been beaten into our heads since …

Read More »

Diabetes Mellitus 101 for Cardiologists, Part 7

In this week’s Homerun Slides, Dr. Stanley Schwartz discusses the “Adipocytokine Syndrome” which he describes as “A New Model for Insulin Resistance and Beta Cell Dysfunction.” He also reviews and compares several diabetes drugs’ effects on insulin resistance and beta cell function as well as other diabetes comorbidities….   To download these …

Read More »

Handbook of Diabetes, 4th Ed., Excerpt #19: Macrovascular Disease in Diabetes

handbook-of-diabetes-image

Rudy Bilous, MD, FRCP Richard Donnelly, MD, PHD, FRCP, FRACP Atherosclerosis For any given age, level of cholesterol or BP, the risk of atherosclerotic cardiovascular disease (CVD) is 3 to 5-fold higher among patients with diabetes compared with subjects without diabetes. Macrovascular complications include fatal and non-fatal coronary heart disease (CHD) events, …

Read More »

Is Type 2 Diabetes an Inflammatory Disease?

Macrophages, a type of immune cell, were found invading pancreatic tissue during the early stages of the disease… Type 2 diabetes is characterized by the loss of beta cells, reduced insulin production and low-grade systemic inflammation. A new study compared healthy mice to obese mice that developed diabetes. The mice were followed …

Read More »